Lonza looking elsewhere after retreating from Patheon bid?
October 21, 2009Manufacturing and Production Lonza
Lonza said it has elected not to proceed with a $460 million bid to buy Canadian contract manufacturing and development …
Andrew Sandham, executive chairman, Syntaxin
October 20, 2009Research and Development appointment, appointments, research and development, syntaxin
Syntaxin, a biopharmaceutical company developing novel biologic drugs that control cell secretion, has appointed Andrew Sandham executive chairman.This follows the …
Cellectis appoints Dr Sylvie Delassus Senior Vice President Communications
October 20, 2009Research and Development appointment, cellectis, research and development
French genome engineering company Cellectis has appointed Dr Sylvie Delassus senior vice president communications and a member of its executive …
Digital Pharma: Raising awareness of clinical trials
October 20, 2009Medical Communications, Research and Development CRO, Quintiles, digi, digital pharma, digital research, patient recruitment
Contract research organisation Quintiles has launched a website for people considering participating in clinical trials. The company hopes Clinicalresearch.com will …
GSK kidney cancer drug approved in US
October 20, 2009Research and Development, Sales and Marketing Cancer, GSK, rcc
GlaxoSmithKline’s Votrient has been approved in the US by the FDA to treat the most common form of kidney cancer.This …
First details emerge of Pfizer site closures
October 20, 2009Research and Development, Sales and Marketing MA, Pfizer, restructure
The completion of Pfizer’s deal to acquire Wyeth has been followed swiftly by news that a number of manufacturing and …
Gail Flockhart joins Fishawack Communications as managing director
October 19, 2009Medical Communications appointment, appointment fishawack, fishawack, medical communications
Fishawack Communications has appointed Gail Flockhart managing director following a restructure of its board of directors.Gail has over two decades …
Cambridge biotech – innovation and global partnerships
October 19, 2009Research and Development Cambridge, ERBI, biotech, regenerative medicine
Just two years ago it cost $10m to sequence a human genome, now for $48,000 you can have a personal …
GSK’s Cervarix finally wins US approval
October 19, 2009Sales and Marketing Cervarix, GSK, US
US regulator the FDA has approved GlaxoSmithKline's cervical cancer vaccine Cervarix, finally allowing the company to bring it to the …
Pharma manufacturing news in brief
October 19, 2009Manufacturing and Production Neopharma
A round-up of developments in the pharmaceutical manufacturing sector, with facility updates from Neopharma, Nextpharma and Arch Pharmalab and new …
AZ-BMS launch Onglyza in Europe
October 19, 2009Sales and Marketing AZ, BMS, DPP-4, Onglyza, diabetes
Bristol-Myers Squibb and AstraZeneca’s long-awaited type II diabetes drug Onglyza has been launched in the UK, its first European market.Designed …
Hannah Stacey, senior account manager, Athena
October 16, 2009Medical Communications Athena, appointment, medical communications
Athena has promoted Hannah Stacey to senior account manager. Hannah has played an integral role in Athena’s new business initiatives …
Digital Pharma: Byte-sized roundup
October 16, 2009Medical Communications Merck, digi, digital pharma, hcsmeu, iphone
Quality regulator slams NHS trusts
October 16, 2009Sales and Marketing NHS, hc
The Care Quality Commission has slammed nearly 50 NHS trusts in its latest annual report on the care which patients …
Johnson & Johnson rides out patent attack
October 16, 2009Sales and Marketing JJ, generics
Profits at Johnson & Johnson have risen in the third quarter, despite deep cuts into pharma sales caused by new …
Lilly finds buyer for threatened manufacturing unit
October 16, 2009Manufacturing and Production Evonik, lilly
Lilly has found a buyer for its manufacturing facility Tippecanoe Laboratories in Indiana, USA, which had been under threat of …
Dr Lisa Rojkjaer, head of clinical development, MorphoSys
October 15, 2009Research and Development appointment, morphosys, research and development
MorphoSys has appointed Dr Lisa Rojkjaer as vice president and head of clinical development. Dr Rojkjaer joins MorphoSys from Novartis …
Linda Dyson, global healthcare practice leader, Cohn & Wolfe
October 15, 2009Medical Communications Cohn & Wolfe, appointment, medical communications
Cohn & Wolfe has appointed Linda Dyson as executive vice president and global healthcare practice leader. She will report to …
Sarah Butterworth and Sarah Lucas join ERL Medicom
October 15, 2009Medical Communications appointment, appointment medicom, medical communications, medicom
ERL Medicom has appointed Sarah Butterworth (pictured) as a director and Sarah Lucas as an account executive.Sarah Butterworth moves to …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
